Pseudomonas aeruginosa is a major life-threatening opportunistic pathogen that commonly infects immunocompromised patients. This bacterium owes its success as a pathogen largely to its metabolic versatility and flexibility. A thorough understanding of P. aeruginosa's metabolism is thus pivotal for the design of effective intervention strategies. Here we aim to provide, through systems analysis, a basis for the characterization of the genome-scale properties of this pathogen`s versatile metabolic 
Introduction
With sequenced genomes now routinely being made available to the public, detailed annotations and various publicly available genomic resources have enabled the formation of genome-scale models of metabolism for a wide variety of organisms (12, 21, 26, 42, 63, 65) . A wealth of data from well-controlled experiments coupled with advancements in methods for computational network analysis have allowed these models to aid interrogation of metabolic behavior. In addition, an iterative process to model development-cycles of in silico model predictions, experimental (i.e., wet-lab) validation, and subsequent model refinement-has enabled the development of methods that have contributed to biological discovery, such as in determination of likely drug targets in Mycobacterium tuberculosis (3, 26) , metabolic engineering of cells for production of valuable compounds (5, 32, 34) , and development of novel frameworks for contextualizing high-throughput 'omics' datasets (15, 24, 64) .
Pseudomonas aeruginosa is a ubiquitous gram-negative bacterium that is capable of surviving in a broad range of natural environments, although it is mostly known for its role as an opportunistic pathogen (40, 60, 72) . While P. aeruginosa is generally found in aerobic environments, it is able to thrive anoxically and, notably, to denitrify (58) . It has
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3 also recently been shown that P. aeruginosa can form biofilms under microaerobic (i.e., very low oxygen) conditions similar to those found in the lungs of cystic fibrosis (CF) patients (1) . These features strongly contribute to the notable success of P. aeruginosa in chronically infecting the lungs of CF patients, nearly all of whom have lifelong P. aeruginosa infections starting at an early age (49, 70) . P. aeruginosa is also a serious pathogen in nosocomial infections and various acute infections in immuno-compromised patients such as severe burns and urinary tract infections (39, 49, 68) . Part of the reason for this remarkable ecological success is thought to be the considerable metabolic versatility and flexibility of P. aeruginosa (62) , which renders the study of metabolism of this life-threatening microbe crucial to the understanding of its pathogenicity and opportunistic nature.
We present a genome-scale metabolic reconstruction of P. aeruginosa PAO1 (hereafter referred to as PAO1), called in silico strain iMO1056 following an often-used naming convention (48) . This model accounts for 1056 genes encoding 1030 proteins that catalyze 883 reactions (see Figure 1a) . Gene-protein-reaction (GPR) associations are accounted for in the reconstruction, as well as the stoichiometry and thermodynamicallyderived directionality of all included reactions. This reconstruction process led to the reannotation of several open reading frames (ORFs). The model was tested against highthroughput substrate utilization experiments (90% match the usage of common substrates) and two published sets of genome-wide knockout data (85% accuracy of essentiality predictions). Several additional predictions were made regarding PAO1 physiology and virulence that may be subsequently tested. This genome-scale reconstruction and subsequent constraint-based modeling enables integrating highthroughput data to generate novel, testable hypotheses that will assist in exploring the physiology of PAO1 and assessing its relevance for pathology.
Materials and Methods

Network Reconstruction
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The reconstruction process is outlined schematically in Figure 2 , and details are described elsewhere (47) . The initial draft of iMO1056 was built from the annotated PAO1 genome available at the Pseudomonas Genome Database (PseudoCAP, www.pseudomonas.com), supplemented by literature mining and BLAST searches (69).
Biological information databases such as EXPASY, KEGG, and TCDB were used to link annotated genes to proteins and proteins to reactions (19, 28, 51) , and confidence values were added to reactions based on the reported confidences from the PseudoCAP annotation. These gene-protein-reaction (GPR) associations link genetic data to reactions in the model and allow the model to predict effects of genetic perturbations on metabolic phenotype. GPR associations are defined through Boolean logic, where for example two protein subunits that combine as a complex to perform one enzymatic function would have an AND relationship with relation to that reaction, whereas two isozymes that are each independently capable of catalyzing a reaction will have an OR relationship.
Gaps in metabolic pathways necessary for cell growth and production of major virulence factors were filled through careful literature mining and homology and context analysis with BLAST on the Pseudomonas Genome Database, NCBI, and other online resources (53) . Genes whose function were inferred via these sources were assigned reaction identification confidence values based on the guidelines of the Pseudomonas Genome Database genome annotation effort for protein name confidence values. This concordance ensures that confidence values for key findings in our study are consistent with confidence values for gene functions in the currently published annotation (69). The PAO1 biomass reaction (defined as a relative weight of metabolites necessary to synthesize biomass, as described previously (66)) was assumed to be similar to the published E. coli biomass reaction albeit with some minor variations to account for PAO1-specific data, as described in supplementary material. Energy efficiency of the electron transport chain in PAO1 was approximated by assuming that P. aeruginosa grown aerobically would have a similar P/O ratio to published values for the model prokaryote Escherichia coli (41) .
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Confidence classes for reactions were assigned based on the PseudoCAP protein name confidence rating system (69), which rates the confidences of gene-protein associations in the PAO1 annotation. We extended the system to rating confidences for reaction associations. There are four levels in this rating system: Class 1, which accounts for genes whose function has been experimentally demonstrated in PAO1; Class 2, which accounts for genes whose function was inferred via homology with an experimentallycharacterized protein in another organism; Class 3, which represents gene-protein associations based on the presence of conserved amino acid motifs; and Class 4, which accounts for genes with similarity to other genes of unknown function. We have adhered to this rating system for genes whose functions were newly annotated in this study ( Table   2 , 'Proposed Confidence' column), and for genes not newly annotated, we have assigned reaction confidences that are equivalent to the protein name confidences in the annotation.
Formulation of the S matrix
In order to perform FBA, a network must first be represented in the form of a stoichiometric matrix (S matrix), as shown in Figure 3a . By convention, rows of the S matrix represent metabolites and columns represent reactions. Reaction substrates have negative coefficients in the S matrix, while products have positive coefficients. The S matrix for a network wholly describes the stoichiometry of reactions in the network. The S matrix also accounts for transport reactions across the cell membrane, represented as reactions interconverting intracellular and extracellular compounds, often coupled with hydrolysis of ATP (in the case of ATP-binding cassette transporters) or exploitation of a chemical gradient (e.g., H + symport or antiport). Figure 3a , for example, illustrates four transport reactions: R 4 , R 5 , R 6 , and R 7 .
Flux balance Analysis
Flux Balance Analysis (FBA) is a computational method that calculates reaction fluxes, their distribution within a metabolic network and, on the basis thereof, growth yields (see
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6 Figure 3 ) (33) . In order to obtain flux predictions, the metabolic network is assumed to be at steady-state, meaning that concentrations of intracellular metabolites do not vary during the course of a simulation. This steady-state assumption, which makes FBA results directly comparable to data from cells at a fixed growth rate (i.e., in exponential phase), is necessary since kinetic parameters are not accounted for in iMO1056.
In many FBA applications, a linear biomass reaction is defined and assumed to be the objective towards which the flux distribution of a network is optimized. The biomass reaction represents a weighted ratio of components forming the dry weight of a cell, as well as hydrolysis of ATP to account for the energy needs involved in growth and cellular maintenance (66). Optimization for biomass is justified by the assumption that bacteria have been evolutionarily optimized for growth, and experimental studies have verified the rationality of this assumption (16, 55) . This optimization step is necessary due to the underdetermined nature of metabolic networks, as a range of flux profiles are possible for a given network. FBA optimization is constrained by the stoichiometry of the network and by upper and lower bounds on reactions as set by thermodynamic and substrate uptake constraints. In addition, conditional constraints can be placed on the system to simulate experimental conditions such as gene knockouts and alternative gene regulation (22, 59 ).
To perform FBA, the flux of the biomass reaction is maximized given the steady-state condition
S·v=0
where S is the stoichiometric matrix representing the network (see Figure 3a) and v is the vector of all fluxes in the network (see Figure 3b , top panel). Ultimately, FBA yields a predicted optimal growth yield and a flux distribution through the system that will support this optimal growth (see Figure 3b , bottom panel). See supplementary material for a discussion of constraints used in FBA simulations in this study.
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BIOLOG experiments
PAO1 was tested for its ability to utilize various carbon sources using BIOLOG GN2 (Mathworks, Inc.).
Results
Metabolic reconstruction of P. aeruginosa PAO1
We generated a constraint-based, genome-scale representation of PAO1's metabolism.
The reconstruction accounts for 1056 genes involved in 883 metabolic reactions (see Aside from accounting for all major pathways necessary for growth of P. aeruginosa, an effort was made to reconstruct some of the major pathways associated with virulence for this bacterium. The metabolism of P. aeruginosa is involved in a number of virulence processes, such as quorum sensing (11, 23) , expression of lipopolysaccharide and rhamnolipids (61) , and notoriously the switch from non-mucoid to mucoid form and associated production of the exopolysaccharide alginate (46) . Table 1 lists the virulenceassociated pathways accounted for in iMO1056 and some relevant features of these pathways.
Systematic Refinement of Genome Annotation
A major value of a manual model-building effort is the careful revision of the current genome annotation based on literature evidence encountered during the model building process, BLAST searches, and gap closures. Annotation refinements represent: (1) knowledge that was in the literature but had been overlooked in the original annotation or (2) new hypotheses that came directly from the model building process. Specifically, the identification of network gaps (instances where a metabolite can be consumed but not produced, or vice-versa) using FBA optimization pinpointed reactions that are necessary for a pathway to function, but that are peripheral to the pathway and thus had been overlooked during historical pathway characterization. Table 2 provides a list of recommended annotation refinements for PAO1 that arose from the reconstruction process. In some cases, such as the annotation refinements of the nuh gene (Table 2) , the
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9 function of the gene is not changed but rather specific reactions which are important for certain cellular processes are assigned to already annotated genes.
The first level of annotation refinement is the assignment of a specific function to a previously uncharacterized gene based on literature evidence or a BLAST search. An example of this in iMO1056 is the gene mtnP (PA3004), which was annotated in
PseudoCAP as "probable nucleoside phosphorylase" but was subsequently found in literature to have the specific function of 5'-methylthioadenosine phosphorylase (see 
searches in the non-redundant NCBI database revealed that PA4457 (thus far annotated as a gene coding for a hypothetical protein) had 79% identity over a length of 326 amino acids to the protein KdsD coded by P. fluorescens Pf-5 (score 501, E-value 3*10 -130 ).
KdsD is an arabinose-5-phosphate isomerase, the enzyme that catalyzes the interconversion of D-arabinose 5-phosphate and D-ribulose 5-phosphate (38) . This reannotation and its subsequent incorporation into the model enabled iMO1056 to grow in silico.
Gap analysis also enables the reconciliation of conflicting knowledge in the literature.
An earlier version of the PAO1 reconstruction was unable to produce biomass in the absence of oxygen. It was discovered through gap analysis that the inability of iMO1056
to grow without oxygen was due to the oxygen-consumption of the enzyme L-aspartate oxidase (NadB), which catalyzes the first step in production of nicotinamide adenine dinucleotide (NAD). Literature mining revealed that while NadB has a strict requirement for O 2 when assayed in vitro, it has been suggested that another electron acceptor might suffice in absence of elemental oxygen in vivo (17). In the network reconstruction, we included an alternate reaction stoichiometry for NadB that had been suggested previously (17), and we thus eliminated the oxygen requirement for growth (see Figure 4d ). Despite this literature analysis, however, it is noteworthy that knocking out nadB is not lethal for P. aeruginosa in vivo (10) . This result suggests that another pathway for NAD biosynthesis likely exists. More detailed biochemical study is necessary to determine if there is another anaerobic path for NAD synthesis in PAO1, and whether NadB truly can function in the absence of oxygen.
Gap analysis was also used to refine stoichiometry and directionality of several reactions that were incorrect or vague in online databases. For instance, the electron transport enzyme NADPH-quinone-oxidoreductase (NADPHQO, PA4975, EC: 1.6.5.5) was found upon analysis of free ATP production to be necessarily irreversible, despite its being listed as 'reversible' in the EXPASY database online (19) . Such network refinements would be difficult to systematize without a genome-scale model that accounts for the interdependency of reactions and metabolites.
Growth predictions
The in silico biomass yield of iMO1056 on glucose minimal medium in steady-state (continuous culture) conditions was calculated using FBA. In silico constraints used for minimal medium conditions are outlined in supplementary material. The maximum specific growth rate was determined to be 1. P. aeruginosa is renowned for its ability to survive by denitrification in anaerobic environments (13, 58) . The pathway for denitrification of nitrate was included in the reconstruction, and iMO1056 is able to grow anaerobically with an in silico biomass yield of 0.0846 gDW·(mmol glc) -1 when nitrate is provided under glucose limitation.
This in silico biomass yield is within 25% of an experimental value of maximum biomass yield reported previously for P. aeruginosa ATCC 9027 under anaerobic growth conditions (0.067 gDW·(mmol glc) -1 ) (7). The ratio of maximum anaerobic yield to maximum aerobic yield reported in (7) is 0.76, which differs from the ratio obtained in silico (0.81) by only 6%, indicating a good match between in silico versus in vivo (experimental) ratios of anaerobic to aerobic yield.
Phenotyping data
A BIOLOG study was performed for P. aeruginosa by cultivating PAO1 in minimal media supplemented with various carbon sources (as described in Materials and Methods). Of the 95 carbon sources tested, 30 could be directly compared to in silico
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growth of iMO1056 (by assuming that substrate utilization indicates growth, which is usually but not always true). Disagreements between the BIOLOG data and the in silico growth simulations were used as hypotheses for refining the network reconstruction. The remaining 65 carbon sources included 15 that were present as intracellular metabolites in iMO1056 but for which there were no transporters assigned, and 50 that are not accounted for currently in the iMO1056 reconstruction. Of these, 14 showed a growth phenotype in the BIOLOG data, indicating that incorporation of these compounds into the model might be a future step in iMO1056 model expansion.
Computational experiments were performed to determine growth of iMO1056 on the 30
BIOLOG carbon sources that were directly testable in iMO1056 (see Figure 5a ). The in silico growth experiments were performed in Simpheny TM using FBA, as described in
Methods. Disagreements between BIOLOG substrate utilization data and in silico growth simulations were investigated through gap analysis and literature mining, and these discrepancies were rectified where possible. In one case (L-leucine), the BIOLOG data was unclear about growth of PAO1, so that datapoint in Figure 5a is shaded lighter than the other carbon sources but is still considered to have a 'growth' phenotype. After completing pathways for substrates which initially conflicted with the BIOLOG dataset, PAO1 viability matched iMO1056 viability in 27 of 30 conditions (see Figure 5a ). This 90% match indicates that the core metabolism and various catabolic pathways of PAO1
were sufficiently reconstructed in iMO1056 for the model to properly predict catabolism of a variety of common substrates, including many amino acids and several common sugars.
The 15 BIOLOG carbon sources that were intracellular metabolites but did not have transporters in iMO1056 gave in silico no-growth phenotypes due to the inability of iMO1056 to uptake these compounds from the environment. We evaluated the cause of these in silico phenotypes by adding a temporary transport reaction to iMO1056 for each carbon source in turn and assessing the new transporter-augmented models for in silico growth. Figure 5b indicates the results of this study, where numbers in the table represent the number of carbon compounds out of 15 total that fall into each of four
possible permutations (growth versus non-growth and in silico versus BIOLOG data, see Figure 5b ). The 10 carbon sources on which PAO1 did not grow in the BIOLOG study (and thus matched the in silico results for iMO1056) were grouped into categories 'correctly lacks transporter' and 'correctly either lacks transporter or pathway,'
depending on whether the transporter-augmented model for that carbon source was able to grow (see Figure 5b ). The 5 carbon sources on which PAO1 did grow in the BIOLOG study (and thus contradicted the in silico results for iMO1056) were grouped into similar categories 'incorrectly lacks transporter' and 'incorrectly lacks pathway and transporter,'
indicating the likely cause of the mismatch between BIOLOG data and in silico simulation. These categorizations will help focus future annotation refinement efforts.
The full list of BIOLOG results can be found in Supplementary material.
Gene essentiality prediction and validation
A list of genes predicted to be essential for in silico growth of iMO1056 were calculated and compared with a set of in vivo essential genes from the literature (i.e., genes that are reported to be required for growth). The set of in vivo essential genes encompasses genes deemed essential in both of two independent genome-scale transposon mutant studies of PAO1 (25, 35) . This overlapping dataset was chosen because it has a higher confidence for gene essentiality than the candidate essentials from either transposon study individually, since the inclusion of two transposon studies increases coverage of the PAO1 genome and thus reduces the number of genes erroneously labeled essential. The set of in vivo essentials includes all genes in the PAO1 genome that were not knocked out in either of the two transposon studies. In silico gene essentiality predictions for iMO1056 were calculated in the Simpheny TM platform via FBA as previously described (27) .
Genes in the in vivo-essential set but not in the iMO1056 reconstruction were assumed to be involved either in non-metabolic functions or in metabolic functions peripheral to central metabolism, and were thus not included in our essentiality analysis. The total accuracy of essentiality predictions was 85% (see Figure 6a ). This accuracy is
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comparable to the 94% accuracy achieved in a recent reconstruction of Bacillus subtilis, which also used genome-scale knockout set for model validation (42) . Of genes in the iMO1056 reconstruction, in silico essentiality predictions match in vivo essentiality for 41% of in vivo essential genes and 91% of in vivo non-essential genes (see Figure 6a ).
Although the total accuracy of predictions is significant, these discrepancies (particularly in matching in vivo essentiality) deserve further discussion (as follows) and can serve as a collection of hypotheses that can be subsequently tested. The in vivo PAO1 transposon studies used in this analysis discuss the possibility of errors in their 'candidate essential genes' sets, and it was suggested in one of the studies that the number of candidate essential genes in that study (678 total) may overestimate the true number of essential genes by 40 to 50% (25) . This overestimate prediction was based on an analysis of the number of ORFs that would likely escape transposon mutagenesis assuming that all base pairs have equal susceptibility to transposon insertion, including essential genes. Due to its higher coverage of the PAO1 genome, the set of overlapping essentials from the two PAO1 studies should have a higher confidence than candidate essentials from either study alone, but the combined transposon set yields an in vivo 'candidate essential' set that is only reduced in size by 34 genes, which does not nearly approximate the 40 to 50% discrepancy suggested (25) . Hence, some of the mismatches
between the in vivo essentials and the in silico essentials are likely due to over-estimation of gene essentiality in the in vivo studies, which would translate into false negatives in the in silico predictions of essentiality.
Additionally, in one of the transposon studies used in our analysis (35) , transposons are reported to likely disrupt genes downstream within an operon, but in the other study (25) , 
Discussion
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We present iMO1056, a genome-scale reconstruction of P. aeruginosa PAO1 that accounts for 1056 genes encoding 1030 proteins that are involved in 883 reactions.
Specifically reconstructed are pathways necessary for growth and for production of common virulence factors, including alginate, rhamnolipids, phenazines, and quorum sensing molecules. iMO1056 was validated with experimental growth rate data from literature, BIOLOG viability data on multiple carbon sources, and a genome-scale gene essentiality set derived from two independent transposon mutant studies in P. aeruginosa.
Model predictions matched well with experimental data in many cases.
Building a genome-scale reconstruction of PAO1 offered insights that would have been difficult to obtain through any other means, including evidence for annotation refinements, the ability to quantitatively predict growth yields and secretion rates under various conditions, and a potential way to probe metabolic stresses incurred by production of various virulence factors that may be explored in future studies. During the model-building process, we were forced to approach each metabolic pathway quantitatively and comprehensively, so previous gaps in knowledge were highlighted and investigated in a rational manner. This process of 'gap analysis' involves coupling in silico growth simulations with bioinformatics searches and literature mining to fill holes in otherwise known pathways, and offers a unique tool for identifying areas of metabolism that require further elucidation. Through gap analysis of P. aeruginosa metabolism, we were able to refine the annotation of a number of genes with respect to their function, directionality, or stoichiometry. Some of these changes are highlighted in Table 2 . These annotation refinements represent many crucial metabolic functions of P.
aeruginosa, and without a systematic network-level approach to guide our analysis, it would have been difficult to highlight these weak points in current knowledge.
As in any genome-scale annotation effort, the network reconstruction process for P.
aeruginosa will require continued work in the future. Mismatches between in vivo and in silico essential genes have highlighted metabolic regions of uncertainty in current knowledge, and these discrepancies still require more work to be adequately explained.
In addition, several pathways in the model remain incomplete due to a lack of available
knowledge. These gaps include synthesis of cofactors (e.g., cobalamin and thiamin) and notably the entire fatty acid β-oxidation pathway, which exists but has not been extensively characterized in pseudomonads to our knowledge (52) . The BIOLOG data also indicated some pathways that should be investigated further in the future, such as substrates that PAO1 utilized but which are not in iMO1056 or for which iMO1056 has no membrane transporter. Furthermore, some pathways were not included in the model despite having been studied in the literature, simply because they were peripheral to the main processes of interest in this study (growth and expression of virulence traits). Thus, for instance, pathways for degrading aromatic compounds and for handling xenobiotics were generally not included in the model, and offer areas for model expansion in the future. Specific validation involving controlled growth experiments with P. aeruginosa will also be informative, and coupling wet-lab and in silico experiments will lend greater insight into both specific functions and global properties of P. aeruginosa metabolism.
Additionally, a genome-scale reconstruction of P. aeruginosa metabolism enables the (4, 60) . Notably, convergent evolution towards loss of virulence factors by P. aeruginosa strains taken from multiple CF patients has been demonstrated, suggesting that virulence traits might be selected against once a stable infection has been achieved (60) . The effect of the loss of the lasR gene, a master regulator of hundreds of virulence-related genes through the quorum sensing system in P. aeruginosa, has also
been evaluated (8, 56) . It was shown that loss of the lasR gene conferred a growth advantage both to strains extracted from the lungs of CF patients and from strains that emerged by selection on rich medium, indicating that optimization of yield could be acting as a metabolic objective even in the CF lung (8) . This result is counterintuitive, as much of the success of P. aeruginosa in chronic lung infections seems to lie in its ability to adopt a slow-growth phenotype, which would suggest that optimization of yield is perhaps not a strong selective pressure in that environment (6) . Regardless of whether slow-growing mutants of P. aeruginosa in the CF lung environment actually optimize for yield, these studies indicate that metabolic selective pressure might be a factor in the evolution of chronic CF strains. With the integration of simple regulatory rules into iMO1056, it will be possible to model different hypotheses about selective pressures in the lung, and analyze the causes for these selective processes.
In addition to the pathogenicity analysis and evolutionary studies outlined above, P. aeruginosa is an organism of much interest for its varying roles as an opportunistic pathogen (60) . From chronic lifelong infections of the lungs of CF patients to acute, highly deadly infections of severe wounds in burn victims, the robustness and environmental diversity of P. aeruginosa are testament to its remarkable natural
metabolic agility. We chose to focus our reconstruction effort on P. aeruginosa PAO1 since it is the most studied P. aeruginosa strain and is also the best characterized, but with minor modifications to iMO1056 the model can be tailored to describe similar species such as the more virulent P. aeruginosa PA14 ( A C C E P T E D 
